CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-18 | Opaleye Management Inc. 10% owner | Purchase | +1,000 | $6.98 | $7K | 102,647 |
| 2021-11-17 | Opaleye Management Inc. 10% owner | Purchase | +8,028 | $6.98 | $56K | 2,472,500 |
| 2021-11-17 | Opaleye Management Inc. 10% owner | Purchase | +1,090 | $6.98 | $8K | 101,647 |
| 2021-11-04 | Opaleye Management Inc. 10% owner | Purchase | +6,000 | $6.50 | $39K | 2,464,472 |
| 2021-11-04 | Opaleye Management Inc. 10% owner | Purchase | +557 | $6.50 | $4K | 100,557 |
| 2021-06-10 | Olivo Martin Sebastian Chief Medical Officer | Purchase | +4,959 | $10.08 | $50K | 9,410 |
| 2021-06-10 | Olivo Martin Sebastian Chief Medical Officer | Purchase | +4,934 | $10.13 | $50K | 14,344 |
| 2021-06-09 | Huang Jane Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-09 | Huang Jane Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-09 | Flannelly Barry P Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-09 | Smith Cynthia Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-09 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-09 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-09 | SARGEN GREGORY Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-09 | GARCEAU ROGER Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-09 | BESHAR LUKE M Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-04-19 | Olivo Martin Sebastian Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2021-01-29 | Smith Cynthia Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-01-29 | Smith Cynthia Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 21,750 | ||
| 2021-01-19 | Davis Blaine Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 12 of 17 · 335 trades